Worldwide Biologic Therapeutics Drugs Industry to 2027 - Rising Prevalence of Chronic Disorders, Including Cancer, Diabetes, and CVD is Driving Growth - ResearchAndMarkets.com

·3 min read

DUBLIN, May 16, 2022--(BUSINESS WIRE)--The "Global Biologic Therapeutics Drugs Market 2021-2027" report has been added to ResearchAndMarkets.com's offering.

The global biologic therapeutics drug market is anticipated to grow at a considerable CAGR during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of chronic disorders, including cancer, diabetes, and CVD.

According to the World Health Organization (WHO), in 2020, the new cancer incidences reported was 19.3 million. Breast cancer was the most common cancer type in 2020 with almost 2.3 million cases, followed by lung cancer with 2.2 million cases, colon and rectum cancer with 1.9 million cases, prostate cancer with 1.4 million cases, and stomach cancer with 1.1 million cases.

The global biologic therapeutics drug market is segmented based on type and application. Based on type, the biologic therapeutics drug market is segmented into blood and blood products, vaccines, human cells and tissues, cellular therapies, allergenic extracts, gene therapies, and others. Based on application, the biologic therapeutics drug market is segmented into rheumatoid arthritis, anemia, cancer, diabetes and others.

Geographically, the global biologic therapeutics drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.

Some of the companies operating in the global biologic therapeutics drug market include Pfizer Inc., AstraZeneca Plc, Novartis International AG, Merck & Co., Inc, and GlaxoSmithKline Plc.

Market Segmentation

  • Global Biologic therapeutics drug market Research and Analysis by Type

  • Global Biologic therapeutics drug market Research and Analysis by Application

The Report Covers

  • Comprehensive research methodology of the global biologic therapeutics drug market.

  • This report also includes a detailed and extensive market overview with key analyst insights.

  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

  • Analysis of regional regulations and other government policies impacting the global biologic therapeutics drug market.

  • Insights about market determinants that are stimulating the global biologic therapeutics drug market.

  • Detailed and extensive market segments with the regional distribution of forecasted revenues.

  • Extensive profiles and recent developments of market players.

Key Topics Covered:

1. Report Summary

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Conclusion

3. Market Determinants

3.1. Motivators

3.2. Restraints

3.3. Opportunities

4. Market Segmentation

4.1. Global Biologic Therapeutics Drug Market by Product Type

4.1.1. Blood and Blood Products

4.1.2. Vaccines

4.1.3. Human Cells & Tissues

4.1.4. Cellular Therapies

4.1.5. Allergenic Extracts

4.1.6. Gene Therapies

4.1.7. Others

4.2. Global Biologic Therapeutics Drug Market by Application

4.2.1. Rheumatoid Arthritis

4.2.2. Anemia

4.2.3. Cancer

4.2.4. Diabetes

4.2.5. Others

5. Regional Analysis

5.1. North America

5.1.1. United States

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain

5.2.5. France

5.2.6. Rest of Europe

5.3. Asia-Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. Rest of Asia-Pacific

5.4. Rest of the World

6. Company Profiles

6.1. Pfizer Inc.

6.2. AstraZeneca Plc

6.3. Novartis International AG

6.4. Merck & Co., Inc.

6.5. GlaxoSmithKline PlC

For more information about this report visit https://www.researchandmarkets.com/r/gs607y

View source version on businesswire.com: https://www.businesswire.com/news/home/20220516005541/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting